In addition, patients with lymph node metastasis had significantly higher expressions of PGM5P2, HERC2P4 and RRN3P2 but lower expressions of HLA-H and RPL13AP20 than those without lymph node metastasis (Figure 2C). Here, RPL13AP20 is linked to metastatic malignant neoplasm in the lymph nodes.